Russian version English version
Volume 20   Issue 2   Year 2025
References

  1. Ohlow M.J., Moosmann B. Phenothiazine: the seven lives of pharmacology’s first lead structure. Drug Discovery Today. 2011;16(3):119–131. doi: 10.1016/j.drudis.2011.01.001
  2. Seghatchian J., Struff W.G., Reichenberg S. Main properties of the THERAFLEX MB-plasma system for pathogen reduction. Transfusion Medicine and Hemotherapy. 2011;38(1):55–64. doi: 10.1159/000323786
  3. Gendrot M., Jardot P., Delandre O., Boxberger M., Andreani J., Duflot I., Le Bideau M., Mosnier J., Fonta I., Hutter S., La Scola B., Pradines B. In vitro evaluation of the antiviral activity of methylene blue alone or in combination against SARS-CoV-2. Journal of Clinical Medicine. 2021;10(14):3007. doi: 10.3390/jcm10143007
  4. Zhukhovitsky V., Shevlyagina N., Zubasheva M., Russu L., Gushchin V., Meerovich G., Strakhovskaya M. Infectivity and Morphology of Bovine Coronavirus Inactivated In Vitro by Cationic Photosensitizers. Viruses. 2022;14(5):1053. doi: 10.3390/v14051053
  5. Bojadzic D., Alcazar O., Buchwald P. Methylene blue inhibits the SARS-CoV-2 spike–ACE2 protein-protein interaction – a mechanism that can contribute to its antiviral activity against COVID-19. Frontiers in Pharmacology. 2021;11:600372. doi: 10.3389/fphar.2020.600372
  6. Fedorov V., Kholina E., Khruschev S., Kovalenko I., Rubin A., Strakhovskaya M. What Binds Cationic Photosensitizers Better: Brownian Dynamics Reveals Key Interaction Sites on Spike Proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2. Viruses. 2021;13(8):1615. doi: 10.3390/v13081615
  7. Kovalenko I., Kholina E., Fedorov V., Khruschev S., Vasyuchenko E., Meerovich G., Strakhovskaya M. Interaction of Methylene Blue with Severe Acute Respiratory Syndrome Coronavirus 2 Envelope Revealed by Molecular Modeling. International Journal of Molecular Sciences. 2023;24(21):15909. doi: 10.3390/ijms242115909
  8. Vasyuchenko E.P., Kholina E.G., Fedorov V.A., Strakhovskaya M.G., Kovalenko I.B., Rubin A.B. Molecular modeling of the methylene blue interaction with the SARS-CoV-2 coronavirus viroporin. Vestnik Moskovskogo universiteta. Seriya 16. Biologiya. 2025;80(2):96–104. doi: 10.55959/MSU0137-0952-16-80-2-4
  9. Li Z., Lang Y., Sakamuru S., Samrat S., Trudeau N., Kuo L., Rugenstein N., Tharappel A., D'Brant L., Koetzner C.A., Hu S., Zhang J., Huang R., Kramer L.D., Butler D., Xia M., Li H. Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo. Emerging Microbes & Infections. 2020;9(1):2404–2416. doi: 10.1080/22221751.2020.1838954
  10. Kaufmann B., Rossmann M.G. Molecular mechanisms involved in the early steps of flavivirus cell entry. Microbes and Infection. 2011;13(1):1–9. doi: 10.1016/j.micinf.2010.09.005
  11. Carbaugh D.L., Lazear H.M. Flavivirus Envelope Protein Glycosylation: Impacts on Viral Infection and Pathogenesis. Journal of Virology. 2020;94(11). Article No. 10.1128/jvi.00104-20. doi: 10.1128/JVI.00104-20
  12. Fibriansah G., Tan J.L., Smith S.A., De Alwis R., Ng T.S., Kostyuchenko V.A., Jadi R.S., Kukkaro P., de Silva A.M., Crowe J.E., Lok S.-M. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nature Communications. 2015;6(1):6341. doi: 10.1038/ncomms7341
  13. Sirohi D., Chen Z., Sun L., Klose T., Pierson T.C., Rossmann M.G., Kuhn R.J. The 3.8 Å resolution cryo-EM structure of Zika virus. Science. 2016;352(6284):467–470. doi: 10.1126/science.aaf5316
  14. PDBFixer. https://github.com/openmm/pdbfixer (accessed 25 September 2025).
  15. Hornak V., Abel R., Okur A., Strockbine B., Roitberg A., Simmerling C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Structure, Function, and Bioinformatics. 2006;65(3):712–725. doi: 10.1002/prot.21123
  16. Luger P., Dittrich B., Benecke L., Sterzel H. Charge density studies on methylene blue – a potential anti-Alzheimer agent. Zeitschrift für Naturforschung B. 2018;73(2):99–108. doi: 10.1515/znb-2017-0165
  17. Khruschev S.S., Abaturova A.M., Diakonova A.N., Ustinin D.M., Zlenko D.V., Fedorov V.A., Kovalenko I.B., Riznichenko G.Yu., Rubin A.B. Multi-particle Brownian Dynamics software ProKSim for protein-protein interactions modeling. Computer Research and Modeling. 2013;5(1):47–64. doi: 10.20537/2076-7633-2013-5-1-47-64
  18. Kim S.Y., Zhao J., Liu X., Fraser K., Lin L., Zhang X., Zhang F., Dordick J.S., Linhardt R.J. Interaction of Zika Virus Envelope Protein with Glycosaminoglycans. Biochemistry. 2017;56(8):1151–1162. doi: 10.1021/acs.biochem.6b01056
  19. Cheng M.L., Yang Y.X., Liu Z.Y., Wen D., Yang P., Huang X.Y., Dong H.L., Xu Y.P., Li X.F., Deng Y.Q. et al. Pathogenicity and structural basis of Zika variants with glycan loop deletions in the envelope protein. Journal of Virology. 2022;96(23). Article No. e00879-22. doi: 10.1128/jvi.00879-22
  20. Goo L., DeMaso C.R., Pelc R.S., Ledgerwood J.E., Graham B.S., Kuhn R.J., Pierson T.C. The Zika virus envelope protein glycan loop regulates virion antigenicity. Virology. 2018;515:191–202. doi: 10.1016/j.virol.2017.12.032
  21. Jolly C.L., Sattentau Q.J. Attachment Factors. In: Viral Entry into Host Cells. Eds. Pöhlmann S., Simmons G. New York: Springer, 2006. P. 1–23. doi: 10.1007/978-1-4614-7651-1_1
Table of Contents Original Article
Vasyuchenko E.P., Strakhovskaya M.G., Kovalenko I.B., Fursova P.V., Rubin A.B. Features of the Electrostatic Interaction of Methylene Blue with the Protein Coat of Flaviviruses. Ìàthematical biology and bioinformatics. 2025;20(2):532-542. doi: 10.17537/2025.20.532
(published in Russian)

Abstract (rus.)
Abstract (eng.)
Full text (rus., pdf)
References

 

  Copyright IMPB RAS © 2005-2026